BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251 | -20.6% | 5 | 0.0% | 0.00% | – |
| Q2 2023 | $316 | +40.4% | 5 | 0.0% | 0.00% | – |
| Q1 2023 | $225 | -77.5% | 5 | -44.4% | 0.00% | – |
| Q3 2022 | $1,000 | – | 9 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 9 | -52.6% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 19 | +111.1% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | -50.0% | 9 | -50.0% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 18 | +100.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 9 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 9 | -10.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 10 | -37.5% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 16 | +23.1% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 13 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |